Vishnu Chemicals FY26 Revenue Surpasses ₹1,600 Crore, PAT Grows 12.3%
Vishnu Chemicals reported record FY26 revenues of ₹1,609.7 crore, up 11.3% YoY. PAT grew 12.3% to ₹142.2 crore. Q4FY26 revenues were ₹450.3 crore (+14.7% YoY), with PAT at ₹43.4 crore (+11.5% YoY). The company is focusing on backward integration and specialty chemicals for future growth.
The announcement details record financial performance, strategic growth initiatives, and positive future outlook, which are material factors for investors.
The company reported record revenues and profitability for both the quarter and the full year, along with positive future growth catalysts and a healthy balance sheet.
Vishnu Chemicals Limited has announced its financial results for the fourth quarter and full financial year ended March 31, 2026. The company achieved record annual and quarterly Revenue, EBITDA, and PAT, driven by strong execution, operational resilience, and strategic integration initiatives.
For the full year FY26, operating revenues reached ₹1,609.7 crore, an increase of 11.3% compared to ₹1,446.5 crore in FY25. EBITDA for the full year stood at ₹252.4 crore, up 10.5% year-on-year. Profit After Tax (PAT) for FY26 was ₹142.2 crore, a growth of 12.3% over FY25.
In the fourth quarter of FY26 (Q4FY26), operating revenues grew by 14.7% year-on-year to ₹450.3 crore, compared to ₹392.6 crore in Q4FY25. EBITDA for the quarter increased by 19.7% to ₹76.7 crore, and PAT rose by 11.5% to ₹43.4 crore.
The company highlighted a balanced revenue mix with domestic and export sales contributing 52% and 48% respectively in FY26, a slight shift from 54% domestic and 46% export in FY25. Vishnu Chemicals also maintained a healthy balance sheet with a Return on Capital Employed (ROCE) of 16.3% and a Debt/Equity ratio of 0.49x. The company's credit rating is CARE A– (Long Term) and CARE A2+ (Short Term).
Future growth catalysts include backward integration, with acquisition completed and integration underway, expected to start phased production from H2FY27. The company has also commercialized Strontium in FY26, which is an import substitute and progressing positively with customer approvals, expecting better capacity utilization in FY27. Additionally, Vishnu Chemicals is developing a new range of high-value specialty chemicals and derivatives for applications in pharmaceuticals, agrochemicals, and electronics.
The leadership expressed gratitude for achieving the milestone of becoming a ₹1,600 crore revenue company, reinforcing their belief in manufacturing excellence and execution discipline for sustainable value creation. They are focused on nurturing complex chemistries and delivering high-quality products with global cost competitiveness.
What to do with a filing like this
Vishnu Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Vishnu Chemicals Limited. Read the original for the full detail.